Tuesday, 19 August 2008

Triaz ( Benzoyl peroxide wash): CAFC clarifies Article III

CAFC ruled that marking products with their applicable patents does not create enough controversy under Article III of the U.S. Constitution to sustain a declaratory judgment suit, upholding the dismissal of a complaint filed against Medicis by a generics manufacturer Prasco for getting noninfringement request.
Medicic got license for its product Triaz ( benzoyl peroxide wash). The patents are listed on the packaging material of the product. Generic player Prasco makes a generic version of said wash by the name Oscion.
In an attempt to avoid the cloud of potential infringement, Prasco filed a declaratory judgment for non-infringement of the listed patents. The case was dismissed for lack of declaratory judgment jurisdiction.

Opinion of court

No comments:

web page statistics
Disclaimer: "IP Pharma Doc" blog is published for information purpose only. "IP Pharma Doc" blog contains no legal advice. I assume no legal responsibility for the views/information expressed here. “IP Pharma Doc” blog is my personal website and not edited by my employer, accordingly, no part of my blog should be attributed to my employer. All information on the present blog should be double checked for its accuracy and applicability. © Dr. Sarwal (2007)
 
eXTReMe Tracker